For several years, our group has been studying the in vivo role of adrenergic and cholinergic mechanisms in the immune-neuroendocrine dialogue in the rat model. The main results of these studies can be summarized as follows: (1) exogenous or endogenous catecholamines suppress PBL functions through alpha-2-receptor-mediated mechanisms, lymphocytes of the spleen are resistant to adrenergic in vivo stimulation, (2) direct or indirect cholinergic treatment leads to enhanced ex vivo functions of splenic and thymic lymphocytes leaving PBL unaffected, (3) cholinergic pathways play a critical role in the "talking back" of the immune system to the brain, (4) acetylcholine inhibits apoptosis of thymocytes possibly via direct effects on thymic epithelial cells, and may thereby influence T-cell maturation, (5) lymphocytes of the various immunological compartments were found to be equipped with the key enzymes for the synthesis of both acetylcholine and norepinephrine, and to secrete these neurotransmitters in culture supernatants Keywords: Neuroimmunomodulation, catecholamines, acetylcholine, lymphocytes, thymic (Plaut, 1987) . Activation of these receptors can exert immunosuppressive or enhancing effects, depending on the respective signal molecule, the type of immune cell concerned (Blalock, 1989) , and the different microenvironments of lymphoid tissues (Felsner et al., 1992; Rinner and Schauenstein, 1991; Rinner et al., 1992) . The generation of neurohormones, neuropeptides, and neurotransmitters by thymocytes and peripheral lymphocytes has been documented in several species (Smith et al., 1990; Rinner and Schauenstein, 1993) , and, on the other hand, neural and endocrine tissues are known to express lymphokines and monokines as well as high densities of their membrane receptors (Velasco et al., 1991; Cunningham and Souza, 1993 Our group is interested in defining the role of the autonomous nervous system within the dialogue between the central nervous system and the immune system. In the rat model, we could show that the in vivo treatment with adrenergic and cholinergic agonists had pronounced and partly opposite effects on ex vivo functions of lymphocytes (Rinner and Schauenstein, 1991; Felsner et al., 1992 Felsner et al., , 1995 , and that the cholinergic system particularly takes part in the signaling from the peripheral immune system to the brain (Rinner and Schauenstein, 1991).
INTRODUCTION
Investigations in the past decades have unraveled close mutual relationships between the neuroendocrine and the immune systems (Cotman et al., 1987; Arnason, 1990) . Central and peripheral lymphoid organs are innervated by the sympathetic and parasympathetic systems with nerve *Corresponding author.
terminals forming "synapsislike" contacts to the immune cells (Bulloch and Moore, 1981; Felten et al., 1987) . Inversely, T lymphocytes were found to regularly invade the central nervous system at random (Hickey et al., 1991) . A great variety of common receptors, surface proteins, and mediators are expressed at high levels in both the neuroendocrine and the immune systems providing information exchange within as well as between the systems. Adrenergic, muscarinic, and nicotinic cholinergic, and many peptidergic receptors have been identified on lymphocytes (Plaut, 1987) . Activation of these receptors can exert immunosuppressive or enhancing effects, depending on the respective signal molecule, the type of immune cell concerned (Blalock, 1989) , and the different microenvironments of lymphoid tissues (Felsner et al., 1992; Rinner and Schauenstein, 1991; Rinner et al., 1992) . The generation of neurohormones, neuropeptides, and neurotransmitters by thymocytes and peripheral lymphocytes has been documented in several species (Smith et al., 1990 ; Rinner and Schauenstein, 1993) , and, on the other hand, neural and endocrine tissues are known to express lymphokines and monokines as well as high densities of their membrane receptors (Velasco et al., 1991; Cunningham and Souza, 1993) . Functionally, cytokines influence endocrine and central nervous functions, including activation of the hypothalamicpituitary adrenal and hypothalamic-godanal axes, induction of fever or slow wave sleep, and signaling to the structures of the "limbic system" (Haas and Schauenstein, 1997) .
Our group is interested in defining the role of the autonomous nervous system within the dialogue between the central nervous system and the immune system. In the rat model, we could show that the in vivo treatment with adrenergic and cholinergic agonists had pronounced and partly opposite effects on ex vivo functions of lymphocytes (Rinner and Schauenstein, 1991; Felsner et al., 1992 Felsner et al., , 1995 , and that the cholinergic system particularly takes part in the signaling from the peripheral immune system to the brain (Rinner and Schauenstein, 1991) .
ALPHA-ADRENERGIC SUPPRESSION OF PBL PROLIFERATIVE RESPONSE IN THE RAT MODEL
The literature data on adrenergic immunoregulation are conflicting; both suppression and enhancement have been reported as a consequence of alpha-or beta-adrenergic stimulation (Hadden et al., 1970; Pearlman, 1971; De Pelchin and Letesson, 1981; Felten et al., 1987; Felten and Felten, 1994; Madden et al., 1995) . These differences are probably due to differences in the experimental approach, such as, for example, in vivo versus in vitro studies, species differences, and epiphenomena due to "handling stress" of laboratory animals .
In In vivo treatment for 24 hr with constant release of pellets containing placebo (C); adrenaline (A); 1.31 _+ 0.04 #g/min propranolol (Pro); 3.13 0.31 #g/min of adrenaline + propranolol (A + Pro); phentolamine (Phe); and 1.32 +_ 0.02 g/min of adrenaline + phentolamine (A + Phe). Rats were implanted subcutaneously with retard tablets containing adrenaline, either alone or in combination with a blocker containing a retard tablet. Placebo tablets consisted of the tablet matrix without a drug. After 24 hr, the animals were killed, blood was collected, and the spleens were excised. Mitogen stimulation was determined in the whole blood and in spleen-cell suspensions after 3 days. Data represent the means _+ SEM of maximal 3HTdR uptake related to the lymphocyte number in culture (CPM/lymphocyte). N 6 for each group.*** p < 0.01 significantly different from controls according to Student's t-test. Our in vivo results are in contrast to reports of betaadrenoceptor-mediated immunosuppression by catecholamines in vitro (Plaut, 1987) and in vivo (Chelmicka-Schorr et al., 1993) . They also suggest that, besides enhanced catecholamine blood levels, adrenenergic immunosuppression requires a bias in the alpha/beta adrenergic receptor balance. Recently, we obtained evidence that endogenous melatonin confers a strong protection to lymphocytes against the suppressive effect of alpha-adrenergic stress. Betaadrenergic blockers inhibit the pineal release of melatonin, and by virtue of this enforce the suppressive effects of catecholamines (Liebmann et al., 1996) .
CHOLINERGIC ENHANCEMENT OF EX VIVO FUNCTIONS OF SPLENIC AND THYMIC LYMPHOCYTES
Since lymphocytes express muscarinic and nicotinic cholinergic receptors and the developing T cells in the thymus are not only in contact with the sympathetic, but also with the parasympathetic cholinergic system, we tested the effects of cholinergic treatment on lymphocyte functions. Sprague Dawley rats were implanted s.c. with retard tablets continuously releasing the muscarinic cholinergic blocker atropine or the inhibitor of acetylcholine esterase physostigmine. After 5 days, the animals were sacrificed and the ex vivo Con A response of lymphocytes was determined. Figure 2 shows (Schauenstein et al., 1987; Sternberg et al., 1990) . We investigated the effect of the chronic administration of physostigmine and/or atropine on the corticosterone response in rats 4 days after i.p. immunization with sheep red blood cells (Figure 3) . Physostigmine abrogated the rise in corticosterone; atropine had no effect, but antagonized the suppression induced by physostigmine. These data provided first evidence that cholinergic mechanisms are involved in the feedback regulation between the immune system and brain. SRBC+A SRBC SRBC+P SRBC+A+B FIGURE 2 Effect of 5 days' treatment with constant release pellets containing placebo, atropine (1.2 mg/day), or physostigmine (0.012 mg/day) on concanavalin-A-stimulated 3H-TdR uptake of lymphocytes from the peripheral blood (WBS, whole-blood stimulation), the spleen, and the thymus. Rats were implanted subcutaneously with retard tablets containing atropine or physostigmine. Placebo tablets consisted of the tablet matrix without a drug. After 5 days, the animals were killed, blood was collected, and the spleens and thymuses were excised. Mitogen stimulation was determined in the whole blood and in spleen-and thymus-cell suspensions after 3 days. ;Each group represents the mean _+ SEM of seven rats. Significance of the difference from placebo-treated animals: p < 0.05 to Student's t-test. (Hirokawa et al., 1986) and fetal thymic lobes,
ACETYLCHOLINE INHIBITS APOPTOSIS OF THYMOCYTES VIA A DIRECT EFFECT ON THYMIC EPITHELIUM AND MAY THEREBY INFLUENCE T-CELL MATURATION
we investigated the effect of this coculture on thymocyte apoptosis and development (Rinner et al., 1994 (Rinner et al., , 1996 ; SRBC+A: administration of atropine (3 mg/kg) on the day of immunization and the following day; SRBC+P: administration of physostigmine (0.3 mg/kg) on the day of immunization and the following day; SRBC+A+P: administration of physostigmine and atropine on the day of immunization and the following day. The animals were killed, corticosterone was extracted from the diluted plasma, and the concentration of corticosterone was determined by RIA. Each group represents the means SEM of eight rats. Statistical difference was determined using ANOVA, followed by Dunnet's t-test. (Blalock, 1989) . We have tested the hypothesis that immune cells are also able to produce neurotransmitters of the autonomous nervous system. Using the methods of Fonnum (1975) (Kawashima et al., 1980) . More studies are needed to explore the secretory mechanism(s) by which lymphocytes release neurotransmitters, and to examine the physiological relevance of these phenomena to immunoregulation in vivo. Nevertheless, the fact that lymphocytes do not only react to but also are able to produce adrenergic and cholinergic neurotransmitters suggests close and mutual relationships to the autonomous nervous system, and may add to the concept of "the immune system as mobile brain."
